4.3 Review

Current understanding of middle east respiratory syndrome coronavirus infection in human and animal models

期刊

JOURNAL OF THORACIC DISEASE
卷 10, 期 -, 页码 S2260-S2271

出版社

AME PUBL CO
DOI: 10.21037/jtd.2018.03.80

关键词

Middle East respiratory syndrome coronavirus (MERS-CoV); epidemiology; animal model; immune response; antiviral therapy

资金

  1. National Natural Science Foundation of China (NSFC) [81772191, 81702047]
  2. State Key Laboratory of Respiratory Disease
  3. Thousand Talents Plan Award of China
  4. Municipal Healthcare Joint-Innovation Major Project of Guangzhou [201604020011]

向作者/读者索取更多资源

Middle East respiratory syndrome (MERS) is a highly lethal respiratory disease caused by a novel betacoronavirus (MERS coronavirus, MERS-CoV). Since its first emergence in 2012, multiple transmission events of MERS-CoV (dromedary to human and human to human) have been reported, indicating that MERS-CoV has the potential to cause widespread outbreak. However, the epidemiology of MERS as well as immune responses against the virus in animal models and patients are still not well understood, hindering the vaccine and therapeutic developments. In this review, we summarize recent genetic and epidemic findings of MERS-CoV and the progress in animal model development, immune response studies in both animals and humans. At last, we discussed the breakthrough on vaccine and therapeutic development which are important against potential future MERS outbreak.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据